SHINVA(SH:600587) Xin Lang Zheng Quan·2025-10-17 05:14Core Viewpoint - Xinhua Medical's stock price has shown slight fluctuations, with a recent decline of 2.02% and a total market capitalization of 9.998 billion yuan, indicating a mixed performance in the market [1]. Financial Performance - For the first half of 2025, Xinhua Medical reported operating revenue of 4.79 billion yuan, a year-on-year decrease of 7.64%, and a net profit attributable to shareholders of 386 million yuan, down 20.35% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amount to 812 million yuan, with 455 million yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased to 39,300, with an average of 15,386 circulating shares per person, a slight decrease of 0.81% from the previous period [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, holding 16.09 million shares (an increase of 196,600 shares), and Hong Kong Central Clearing Limited, holding 7.92 million shares (an increase of 413,000 shares) [3]. Business Overview - Xinhua Medical, established on April 18, 1993, and listed on September 27, 2002, is primarily engaged in the manufacturing of medical devices and pharmaceutical equipment, with a business structure that includes medical trade and services [1]. - The revenue composition of Xinhua Medical is as follows: medical device manufacturing 35.16%, medical trade 31.23%, pharmaceutical equipment 24.43%, medical services 7.05%, and others 2.12% [1].